ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome

Anne Grünewald1, Björn Arns, Philip Seibler

  • 1Section of Clinical and Molecular Neurogenetics, Department of Neurology, University of Lübeck, Lübeck, Germany.

Neurobiology of Aging
|February 3, 2012
PubMed

Insights

Mutations in ATPase type 13A2 (ATP13A2) disrupt mitochondrial function, leading to decreased ATP synthesis and increased DNA damage in Kufor-Rakeb syndrome patients. Restoring ATP13A2 function improved mitochondrial respiration, suggesting impaired clearance contributes to this parkinsonism.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Mutations in the ATP13A2 gene are linked to autosomal-recessive parkinsonism, known as Kufor-Rakeb syndrome (KRS).
  • Several proteins associated with parkinsonism play roles in mitochondrial dynamics and mitophagy (the clearance of damaged mitochondria).

Purpose of the Study:

  • To investigate the impact of endogenous ATP13A2 mutations on mitochondrial function in KRS patient fibroblasts.
  • To explore the role of ATP13A2 in maintaining mitochondrial health and the potential involvement of impaired mitochondrial clearance in KRS pathogenesis.

Main Methods:

  • Fibroblast cell cultures from KRS patients and healthy controls were used for comparative analysis.
  • Mitochondrial function was assessed by measuring adenosine triphosphate (ATP) synthesis rates, mitochondrial DNA (mtDNA) levels and lesions, oxygen consumption rates, and mitochondrial network morphology.
  • The effect of wild-type ATP13A2 overexpression on the observed mitochondrial phenotypes was evaluated.

Main Results:

  • KRS patient fibroblasts exhibited significantly decreased ATP synthesis rates and increased levels of mitochondrial DNA lesions.
  • Oxygen consumption rates were elevated, and the mitochondrial network showed increased fragmentation in patient cells.
  • Overexpression of wild-type ATP13A2 was found to rescue the mitochondrial respiration defects.

Conclusions:

  • ATP13A2 plays a crucial role in maintaining a healthy mitochondrial pool.
  • Impaired mitochondrial clearance is a likely pathogenic mechanism contributing to Kufor-Rakeb syndrome.
  • These findings highlight the link between ATP13A2, mitochondrial homeostasis, and neurodegeneration in KRS.

Related Concept Videos

ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial precursors...